Attached files

file filename
EX-99.1 - WOUND MANAGEMENT TECHNOLOGIES, INC. PRESS RELEASE ANNOUNCING CONFERENCE CALL ON FIRST QUARTER 2015 RESULTS. - Sanara MedTech Inc.wndm_ex991.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): April 20, 2015

Wound Management Technologies, Inc.
(Exact name of registrant as specified in its charter)

Texas
 
000-11808
 
59-2219994
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
16633 Dallas Parkway, Suite 250
Addison, Texas
 
75001
(Address of principal executive offices)
(zip code)
 
Registrant’s telephone number, including area code: (972) 218-0935

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
       


 
 
 
 
 
Item 7.01
Regulation FD Disclosure

The information provided pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing or other document filed by Wound Management Technologies, Inc. pursuant to the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. The information provided pursuant to this Item 7.01 shall instead be deemed “furnished.”
    
On April 20, 2015, Wound Management Technologies, Inc. (the "Company") announced that it will conduct an earnings conference call on Wednesday, April 22, 2015 at 3:00 p.m. CST during which the Company will discuss first quarter 2015 results and provide an update on recent activities. The press release announcing the conference call information is attached as Exhibit 99.1.
 
Item 9.01
Financial Statements and Exhibits

(d) Exhibits.

Exhibit 99.1    Wound Management Technologies, Inc. press release announcing conference call on first quarter 2015 results.
 
 
 

 
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
Wound Management Technologies, Inc.
 
       
Date: April 20, 2015
By:
/s/ Darren Stine  
   
Darren Stine
 
   
Chief Financial Officer